Understanding the New ICH-M14 Safety Guidelines
Today, the pharmaceutical industry is moving toward a massive transformation. A historic change occurred when a global organization called the International Council for Harmonization officially adopted a new framework named the ICH M14 guideline. This framework changes the rulebook for drug safety.
Moving Beyond the Sandbox: How to Build Inspection-Ready AI in Regulated Life Sciences
For years, AI was just a tool for simple tasks like drafting emails. Those days of casual use are over. Regulators are tightening expectations, demanding strict AI governance, perfect traceability, and full integration with quality compliance systems. These rules are no longer optional best practices.
The Rise of Patient-Centric Packaging in Pharmaceuticals
In recent years, the pharmaceutical industry has begun to rethink its approach to drug packaging. No longer is packaging only a protective shell for medicines. Today, it is evolving into something much more meaningful: a bridge between drug makers and patients. This shift is called patient-centric packaging. In this post, we will explore what patient-centric packaging is, why it matters, and how it is transforming the way medicines are delivered and used.
The Advantages of Bringing Pharmaceutical CMOs Back to the United States
Bringing CMOs back to the United States
Navigating the Current Regulatory Climate
Here are some ways Metis Consulting Services could help your organization meet the challenges highlighted in a survey * of over 200 regulatory, safety, and quality directors from small to medium-sized biotechs in the EU (Ireland) and North America (U.S.)